106 related articles for article (PubMed ID: 12127486)
1. A protein-farnesyl transferase inhibitor interferes with the serum-induced conversion of Candida albicans from a cellular yeast form to a filamentous form.
McGeady P; Logan DA; Wansley DL
FEMS Microbiol Lett; 2002 Jul; 213(1):41-4. PubMed ID: 12127486
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of a Candida albicans GGTase I inhibitor-alanine conjugate. Inhibition of Rho1p prenylation in C. albicans.
Murthi KK; Smith SE; Kluge AF; Bergnes G; Bureau P; Berlin V
Bioorg Med Chem Lett; 2003 Jun; 13(11):1935-7. PubMed ID: 12749902
[TBL] [Abstract][Full Text] [Related]
3. RAM2: an essential gene in the prenylation pathway of Candida albicans.
Song JL; White TC
Microbiology (Reading); 2003 Jan; 149(Pt 1):249-59. PubMed ID: 12576598
[TBL] [Abstract][Full Text] [Related]
4. An extract of Morinda citrifolia interferes with the serum-induced formation of filamentous structures in Candida albicans and inhibits germination of Aspergillus nidulans.
Banerjee S; Johnson AD; Csiszar K; Wansley DL; McGeady P
Am J Chin Med; 2006; 34(3):503-9. PubMed ID: 16710899
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory activity to protein prenylation and antifungal activity of zaragozic acid D3, a potent inhibitor of squalene synthase produced by the fungus, Mollisia sp. SANK 10294.
Tanimoto T; Ohya S; Tsujita Y
J Antibiot (Tokyo); 1998 Apr; 51(4):428-31. PubMed ID: 9630865
[TBL] [Abstract][Full Text] [Related]
7. Carvone and perillaldehyde interfere with the serum-induced formation of filamentous structures in Candida albicans at substantially lower concentrations than those causing significant inhibition of growth.
McGeady P; Wansley DL; Logan DA
J Nat Prod; 2002 Jul; 65(7):953-5. PubMed ID: 12141851
[TBL] [Abstract][Full Text] [Related]
8. 2-Arylindole-3-acetamides: FPP-competitive inhibitors of farnesyl protein transferase.
Trotter BW; Quigley AG; Lumma WC; Sisko JT; Walsh ES; Hamann CS; Robinson RG; Bhimnathwala H; Kolodin DG; Zheng W; Buser CA; Huber HE; Lobell RB; Kohl NE; Williams TM; Graham SL; Dinsmore CJ
Bioorg Med Chem Lett; 2001 Apr; 11(7):865-9. PubMed ID: 11294379
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase synthesis of novel inhibitors of farnesyl transferase.
Barber AM; Hardcastle IR; Rowlands MG; Nutley BP; Marriott JH; Jarman M
Bioorg Med Chem Lett; 1999 Feb; 9(4):623-6. PubMed ID: 10098677
[TBL] [Abstract][Full Text] [Related]
10. In vitro effect of DNA topoisomerase inhibitors on Candida albicans.
Kwok SC; Schelenz S; Wang X; Steverding D
Med Mycol; 2010 Feb; 48(1):155-60. PubMed ID: 19626543
[TBL] [Abstract][Full Text] [Related]
11. Farnesyl protein transferase inhibition interferes with activation of MAP kinase family members in human peripheral blood monocytes.
Vervenne WL; Bos CL; Rens LS; Peppelenbosch MP; Richel DJ
Mol Med; 2002 Dec; 8(12):857-62. PubMed ID: 12606821
[TBL] [Abstract][Full Text] [Related]
12. Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasis.
Buckner FS; Eastman RT; Yokoyama K; Gelb MH; Van Voorhis WC
Curr Opin Investig Drugs; 2005 Aug; 6(8):791-7. PubMed ID: 16121685
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans.
Hsu CC; Lai WL; Chuang KC; Lee MH; Tsai YC
Med Mycol; 2013 Jul; 51(5):473-82. PubMed ID: 23210679
[TBL] [Abstract][Full Text] [Related]
14. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G
Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343
[TBL] [Abstract][Full Text] [Related]
15. Synergism of aminobisphosphonates and farnesyl transferase inhibitors on tumor metastasis.
Andela VB; Rosenblatt JD; Schwarz EM; Puzas EJ; O'Keefe RJ; Rosier RN
Clin Orthop Relat Res; 2002 Apr; (397):228-39. PubMed ID: 11953614
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans.
Simonetti G; Passariello C; Rotili D; Mai A; Garaci E; Palamara AT
FEMS Yeast Res; 2007 Dec; 7(8):1371-80. PubMed ID: 17627775
[TBL] [Abstract][Full Text] [Related]
17. Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells.
Le Gouill S; Pellat-Deceunynck C; Harousseau JL; Rapp MJ; Robillard N; Bataille R; Amiot M
Leukemia; 2002 Sep; 16(9):1664-7. PubMed ID: 12200678
[TBL] [Abstract][Full Text] [Related]
18. Testing antivirals against hepatitis delta virus: farnesyl transferase inhibitors.
Bordier BB; Glenn JS
Methods Mol Med; 2004; 96():539-53. PubMed ID: 14762290
[No Abstract] [Full Text] [Related]
19. Effective killing of the human pathogen Candida albicans by a specific inhibitor of non-essential mitotic kinesin Kip1p.
Chua PR; Roof DM; Lee Y; Sakowicz R; Clarke D; Pierce D; Stephens T; Hamilton M; Morgan B; Morgans D; Nakai T; Tomasi A; Maxon ME
Mol Microbiol; 2007 Jul; 65(2):347-62. PubMed ID: 17573815
[TBL] [Abstract][Full Text] [Related]
20. Identification of inhibitors of yeast-to-hyphae transition in Candida albicans by a reporter screening assay.
Heintz-Buschart A; Eickhoff H; Hohn E; Bilitewski U
J Biotechnol; 2013 Mar; 164(1):137-42. PubMed ID: 23262131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
